These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28500685)

  • 21. Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications.
    Marzano AV; Tedeschi A; Fanoni D; Bonanni E; Venegoni L; Berti E; Cugno M
    Br J Dermatol; 2009 Feb; 160(2):266-72. PubMed ID: 18945300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes.
    Riani M; Le Jan S; Plée J; Durlach A; Le Naour R; Haegeman G; Bernard P; Antonicelli F
    J Allergy Clin Immunol; 2017 Mar; 139(3):863-872.e3. PubMed ID: 27637385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-16 expression and release in bullous pemphigoid.
    Frezzolini A; Cianchini G; Ruffelli M; Cadoni S; Puddu P; De Pità O
    Clin Exp Immunol; 2004 Sep; 137(3):595-600. PubMed ID: 15320912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid.
    Zuo Y; Evangelista F; Culton D; Guilabert A; Lin L; Li N; Diaz L; Liu Z
    J Autoimmun; 2016 Sep; 73():111-9. PubMed ID: 27377454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.
    Bhol KC; Rojas AI; Khan IU; Ahmed AR
    Cytokine; 2000 Jul; 12(7):1076-83. PubMed ID: 10880254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCL18 is expressed in patients with bullous pemphigoid and parallels disease course.
    Günther C; Carballido-Perrig N; Kopp T; Carballido JM; Pfeiffer C
    Br J Dermatol; 2009 Apr; 160(4):747-55. PubMed ID: 19120345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct compartmentalization of immune cells and mediators characterizes bullous pemphigoid disease.
    Margaroli C; Bradley B; Thompson C; Brown MR; Giacalone VD; Bhatt L; Stoff B; Ahuja S; Springman E; Tirouvanziam R; Feldman RJ
    Exp Dermatol; 2020 Dec; 29(12):1191-1198. PubMed ID: 33047366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes.
    Schmidt E; Reimer S; Kruse N; Jainta S; Bröcker EB; Marinkovich MP; Giudice GJ; Zillikens D
    J Invest Dermatol; 2000 Nov; 115(5):842-8. PubMed ID: 11069622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
    Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
    Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
    Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
    J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases.
    Moriuchi R; Nishie W; Ujiie H; Natsuga K; Shimizu H
    J Dermatol Sci; 2015 Apr; 78(1):21-5. PubMed ID: 25724363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eosinophils as putative therapeutic targets in bullous pemphigoid.
    Simon D; Borradori L; Simon HU
    Exp Dermatol; 2017 Dec; 26(12):1187-1192. PubMed ID: 28833620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating IgE anti-BP180 autoantibody and its correlation to clinical and laboratorial aspects in bullous pemphigoid patients.
    Ma L; Wang M; Wang X; Chen X; Zhu X
    J Dermatol Sci; 2015 Apr; 78(1):76-7. PubMed ID: 25797173
    [No Abstract]   [Full Text] [Related]  

  • 34. Eosinophil localization to the basement membrane zone is autoantibody- and complement-dependent in a human cryosection model of bullous pemphigoid.
    Messingham KN; Wang JW; Holahan HM; Srikantha R; Aust SC; Fairley JA
    Exp Dermatol; 2016 Jan; 25(1):50-5. PubMed ID: 26475989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins.
    Borrego L; Maynard B; Peterson EA; George T; Iglesias L; Peters MS; Newman W; Gleich GJ; Leiferman KM
    Am J Pathol; 1996 Mar; 148(3):897-909. PubMed ID: 8774144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic accuracy of BP180 NC16a and BP230-C3 ELISA in serum and saliva of patients with bullous pemphigoid.
    Esmaili N; Mortazavi H; Kamyab-Hesari K; Aghazadeh N; Daneshpazhooh M; Khani S; Chams-Davatchi C
    Clin Exp Dermatol; 2015 Apr; 40(3):324-30. PubMed ID: 25476471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.
    Goyal N; Rao R; Shenoi SD; Pai S; Kumar P; Bhogal BS; Schmidt E; Zillikens D
    Indian J Dermatol Venereol Leprol; 2017; 83(5):550-555. PubMed ID: 28749386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.
    Liu Z; Sui W; Zhao M; Li Z; Li N; Thresher R; Giudice GJ; Fairley JA; Sitaru C; Zillikens D; Ning G; Marinkovich MP; Diaz LA
    J Autoimmun; 2008 Dec; 31(4):331-8. PubMed ID: 18922680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid.
    Dimson OG; Giudice GJ; Fu CL; Van den Bergh F; Warren SJ; Janson MM; Fairley JA
    J Invest Dermatol; 2003 May; 120(5):784-8. PubMed ID: 12713582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptive and innate immune pathogenesis of bullous pemphigoid: A review.
    Yan T; Zhang Z
    Front Immunol; 2023; 14():1144429. PubMed ID: 36993969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.